Interleukin-13 Antibody Composition

Patent No. EP1942939 (titled "Interleukin-13 Antibody Composition") was filed by Medimmune on Sep 29, 2006. The application was issued on Jul 7, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DERMIRAFeb 28, 2019VENNER SHIPLEY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1942939

MEDIMMUNE
Application Number
EP06794604A
Filing Date
Sep 29, 2006
Status
Patent Maintained As Amended
Jun 12, 2021
Publication Date
Jul 7, 2021